NewsRoom Articles - Page 39 of 154 - PsychedelicNewsWire (PNW)

ThursdayFeb 09, 2023 1:04 pm

Study Links Use of Classic Psychedelics to Positive Behaviors

Psychedelics have been getting an inordinate amount of media attention in recent years due to their medical potential. Although federal law forbids the production, sale and use of psychedelics, loosening policies have allowed researchers to conduct more research on hallucinogenic drugs such as psilocybin and MDMA. Initial research has revealed that these and other psychedelics may be able to alleviate symptoms of moderate to severe mental health disorders when paired with psychotherapy. As such, lawmakers in several states and even other nations such as Australia are working to loosen the restrictions on psychedelics and allow more research. A study that…

WednesdayFeb 08, 2023 1:18 pm

Australia First in Line to Categorize Psychedelics as Medicinal

Australia recently made history when it categorized psychedelics as medicines, becoming the first country in the world to grant the distinction to hallucinogenic drugs. Psychedelics have been subject to an increasing amount of research in recent years amid a rising push for alternative mental health treatments. Hallucinogenic drugs such as psilocybin and ketamine have exhibited a range of potential medical benefits against mental health disorders in a variety of clinical trials. However, the fact that these substances are largely illegal worldwide has hindered further research and made it nearly impossible for people who could benefit from psychedelic-assisted therapies to access…

TuesdayFeb 07, 2023 12:47 pm

Colorado Governor Announces Psychedelic Advisory Board Membership

At the start of the year, the Colorado Department of Regulatory Agencies (DORA) began searching for individuals to join an advisory board that would be responsible for informing on psychedelic policy. As part of those efforts, DORA promoted a web page where interested professionals could fill out applications to join the state’s first-ever Medicine Advisory Board. Nearly a month later, Colorado governor Jared Polis announced the appointment of 15 members to the Natural Medicine Advisory Board. The 15-member board will be tasked with studying and making recommendations on matters related to psychedelics law. Voters in Colorado voted in favor of…

MondayFeb 06, 2023 11:28 am

Research Highlights Possibility of Trip-Free Psychedelics

Psychedelics are poised to revolutionize the psychiatric industry over the next few decades. This is because initial research into hallucinogenic drugs has revealed that they may be able to alleviate the symptoms of mental health disorders such as post-traumatic stress disorder. Studies have found that even a single dose of a psychedelic, such as ketamine and psilocybin, can result in long-term benefits without most of the side effects typically seen in pharmaceutical mental health drugs. However, these hallucinogenic drugs are still psychoactive despite their therapeutic benefits, and patients usually have to go through a guided psychedelic experience, or “trip,” once…

FridayFeb 03, 2023 11:12 am

Senators in Virginia Approve Measure Rescheduling Psilocybin

Drug reform supporters in Virginia recently secured a major win after Virginia senators voted in favor of a psilocybin-rescheduling bill. The initiative, introduced by Senator Ghazala Hashmi, would reschedule psilocybin to a lower schedule and establish a psilocybin advisory board to oversee the study of the psychedelic’s therapeutic potential. The bill received overwhelming approval from the Senate Education and Health Subcommittee on Health Professions and passed after a 6 to 1 vote in its favor. Interestingly, the legislation, which will now advance to the full committee for further consideration, is a narrower version of a bill Hashmi filed during the…

ThursdayFeb 02, 2023 12:44 pm

Why You Shouldn’t Worry About Addiction Risk in Ketamine Infusions

The past couple of years have seen a surge in psychedelic research that has revealed potential therapeutic benefits in using hallucinogenic drugs such as ketamine and psilocybin to treat mental health issues. Although most of this research is in its infancy due to prohibitionist laws that have prevented psychedelic research for decades, the findings are extremely promising. Researchers have found that even a single dose of a psychedelic such as ketamine can result in profound and long-lasting mental health benefits. As such, Big Pharma and investors are pouring millions of dollars into the research and development of psychedelic-assisted therapies. With…

WednesdayFeb 01, 2023 12:50 pm

Congressional Researchers Highlight Rift Between State-Level, Federal Drug Laws

Dozens of states have launched medical and recreational cannabis industries over the past two decades amid a wave of drug reform that has swept across the country. In the past couple of years, reformists in several states have also begun campaigns to legalize, or at least decriminalize, psychedelic drugs as initial research has shown that those drugs have potential as mental health treatments. However, while states are increasingly adopting permissive drug policies, federal law still bans the production, distribution and use of drugs such as cannabis and psychedelics even though millions of people across the country now use them either…

TuesdayJan 31, 2023 12:42 pm

Study Looks into Effects of Hallucinogenic Mushrooms on Bipolar Disorder

Bipolar disorder is a mental illness affecting 2.8% of the U.S. population and around 46 million people worldwide. The disorder is characterized by extreme mood swings that include emotional lows (depression) and highs (mania or hypomania). Although there is no permanent cure for bipolar disorder, the condition and its symptoms can be managed through treatments such as mood stabilizers, antidepressants and atypical antipsychotics. In addition, researchers are always on the hunt for safer and more effective treatments for complex mental diseases such as bipolar disorder. A study that was recently published in the “Journal of Psychopharmacology” sought to understand the…

MondayJan 30, 2023 11:24 am

VA Official Highlights Need for Psychedelic Guidance for Veterans

During a recent webinar, an official of the Department of Veterans Affairs revealed that the agency was closely observing psychedelics policy and research as the reform wave continued to sweep across states in the country. Dr. Ilse Wiechers, deputy executive director of the Office of Mental Health and Suicide Prevention, offered insights into the VA’s view on psychedelics. Wiechers stated that the department had been working on plans to progress its policies on psychedelics, revealing that some officials had also held meetings with external and internal stakeholders including agencies funding research on psychedelics. She continued that while the VA wasn’t…

FridayJan 27, 2023 10:47 am

Oregon Bill Seeks to Track Legal Users of Psychedelics

During the November 2020 elections, voters in the state of Oregon approved ballot measure 109, which directed that the state’s Health Authority license and regulate the manufacture, purchase, sale, transportation and delivery of psilocybin products as well as the provision of psilocybin services. The resolution also prevented the state’s government from collecting sensitive information from individuals without consent. It did so by deliberately failing to use a medical model in an effort to make psilocybin services available for different purposes outside of therapy. This meant that clients who accessed these services wouldn’t qualify for protection under the federal law that…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000